Table 1.

Screening Recommendations for PWID Admitted With Serious Injection-Related Infections

Screening Tests
HIV	HIV ½ Ab + P24 Ag at initial visit [32, 9]; screen every 3 months if ongoing substance use.
Hepatitis B virus	HBV surface Ag at each visit. Evaluate immunity at initial visit with HBV surface antibody and core antibody. Immunize if nonimmune. Link patients with active HBV to infectious diseases care [32, 9].
Hepatitis C virus	HCV Ab at initial visit. If positive, obtain HCV RNA and link to HCV treatment for viremic patients [32, 9].
Syphilis	RPR should be assessed at initial visit. Additional testing as indicated by sexual health history [9].
Gonorrhea and chlamydia	Gonorrhea and chlamydia nucleic acid amplification testing (urine) at initial visit. Additional pharyngeal or rectal testing as indicated by sexual health history [33, 9].

Abbreviations: Ab, antibody; HBV, hepatitis B virus; HCV, hepatitis C virus; RPR, rapid plasma reagin.